Technology
Health
Biotechnology

CSL Limited

$79.30
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.55 (-0.69%) Today
+$0.18 (0.23%) As of 5:00 PM EDT after-hours

Why Robinhood?

You can buy or sell CSL Limited and other stocks, options, ETFs, and crypto commission-free!

About CSLLY

Csl Ltd SPONSORED ADR (Australia), also called CSL Limited, is a biopharmaceutical company, which engages in the research, development, manufacture, marketing and distribution of biopharmaceutical and allied products. It operates through the CSL Behring and Seqirus segments. Read More The CSL Behring segment provides plasma-derived and recombinant products, and operates plasma collection networks through CSL Plasma. The Seqirus segment manufactures and distributes non-plasma biotherapeutic products and develops influenza related products. The company was founded on November 2, 1961 and is headquartered in Parkville, Australia. CSLLY is listed on the Pink Current market tier. OTC market data is provided by OTC Markets Group, Inc (otcmarkets.com).

Employees
22,220
Headquarters
Parkville, Victoria (VIC)
Founded
1961
Market Cap
71.68B
Price-Earnings Ratio
39.86
Dividend Yield
1.05
Average Volume
26.63K
High Today
$79.70
Low Today
$79.12
Open Price
$79.67
Volume
22.95K
52 Week High
$83.12
52 Week Low
$60.89

Collections

Technology
Health
Biotechnology
2014 IPO

CSLLY News

Reuters48m

Australia shares slip on faded hopes for big Fed rate cut; NZ rises

1

More CSLLY News

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.